SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 209.02+3.2%Nov 10 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (22691)6/25/1998 11:09:00 AM
From: JOEBT1  Read Replies (2) of 32384
 
HENRY--Thank you for the abstracts--I read them all but did not understand even superficially most of them. I did conclude that Targretin is not going to be useful for CTCL because of the side effects. Is that correct? It would be very useful if for each of these abstracts you could give a brief translation of the work and its importance. Otherwise 90% of these abstracts are noise--in other words I understand only 10% of these abstracts. TIA.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News